Pediatric Long-Term Follow-up and Rollover Study
Running, not enrolling · Phase 4
Conditions studied: Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneuronal Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1
In brief
A roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
Key facts
- Study ID
- NCT03975829
- Run by
- Novartis Pharmaceuticals
- People needed
- 163
- Starts
- 2019-11-04
- Expected to finish
- 2026-11-05
- Last updated by the study team
- 2026-07-07
Who can join
Age: 1 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Childrens National Hospital — Washington D.C., District of Columbia, United States
- Nicklaus Childrens Hospital — Miami, Florida, United States
- Indiana Uni School of Medicine — Indianapolis, Indiana, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- University of Minnesota — Minneapolis, Minnesota, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Memorial Sloan Kettering Cancer Ctr — New York, New York, United States
- Cinn Children Hosp Medical Center — Cincinnati, Ohio, United States
- St Jude Childrens Research Hospital — Memphis, Tennessee, United States
- Texas Childrens Hospital — Houston, Texas, United States
- Novartis Investigative Site — CABA, Buenos Aires, Argentina
- Novartis Investigative Site — Darlinghurst, New South Wales, Australia
- Novartis Investigative Site — Parkville, Victoria, Australia
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Barretos, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — São Paulo, São Paulo, Brazil
- Novartis Investigative Site — Vancouver, British Columbia, Canada
- Novartis Investigative Site — Toronto, Ontario, Canada
- Novartis Investigative Site — Montreal, Quebec, Canada
- Novartis Investigative Site — Brno, Czechia
- Novartis Investigative Site — Prague, Czechia
- Novartis Investigative Site — Copenhagen, Denmark
- Phoenix Children s Hospital — Phoenix, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.